Covid-19 Impact on Spinal Cord Stimulation Devices Market Size to surge at 8.7% CAGR is expected to reach $3.58 Billion in 2026

March 2021 | Report Format: Electronic (PDF)

Spinal Cord Stimulation Devices Market Growth & Trends

The global spinal cord stimulation devices market size is anticipated to reach USD 3.58 billion by 2026 registering a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Increasing incidence of failed back syndrome and complex regional pain syndrome is anticipated to boost the market growth. Failed back syndrome occurs as a chronic pain after spinal surgeries for back or leg pain. After spinal surgery, the pain gets reduced or the condition may get worst due to scar tissue which build up around the spinal nerve roots.

Spinal cord stimulation device is used to treat patients who failed to get the result from spinal surgeries, by blocking the pain before it reaches the brain. Thus, increasing number of patients suffering from chronic pain after surgeries is likely to augment the product demand over the forecast period. In addition, technological advancements are expected to fuel the market growth further. For instance, Medtronic’s Intellis is a smallest implantable spinal cord stimulator designed to overcome limitations with the current systems.

The high dose therapy of the device helps reduce the pain for the patients suffering from diseases, such as degenerative disk disease. Key companies are introducing technologically enhanced products to gain competitive advantage in the industry. For instance, in January 2019, Boston Scientific launched its Spectra WaveWriter spinal cord stimulator in Europe. It is used for the treatment of chronic pain through electrical impulses. This new system also allows physicians and patients to customize their therapy.

Request a free sample copy or view report summary: 
Spinal Cord Stimulation Devices Market Report

Spinal Cord Stimulation Devices Market Report Highlights

  • Rechargeable device segment led the global market in 2018 and is projected to expand further at the fastest CAGR from 2018 to 2026
  • This is attributed to the factors, such as new product launches by key companies and increasing number of patients suffering from neuropathic pain
  • Failed back syndrome was the dominant application segment in 2018 owing to high number of patients suffering from pain after spinal surgeries
  • North America led the global spinal cord stimulation devices market in 2018 owing to the increased incidence of post-laminectomy syndrome followed by chronic longstanding back pain

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Create a website or blog at WordPress.com

Up ↑

Create your website with WordPress.com
Get started
%d bloggers like this: